The Clearview Malaria rapid test range from Inverness Medical provides a complete, rapid diagnostic solution for in vitro detection of malarial antigens in whole blood.
It is available in two different formats: Clearview Malaria Pf is a qualitative test for detecting the most common, virulent and deadly malaria-causing parasite, Plasmodium falciparum; and Clearview Malaria Combo detects and differentiates between the Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae and Plasmodium ovale antigens.
Both of these rapid tests detect antigens from capillary or venous whole-blood and provide easy-to-interpret results in just 15 minutes.
Between one- and two-million deaths each year are attributed to malaria.
Deaths and transmission can be significantly reduced if infection is accurately diagnosed and effectively treated.
Ideal for remote health centres, the Clearview Malaria rapid test range is manufactured to meet the harsh conditions of malaria endemic regions.
The tests can withstand high temperatures, lack of refrigeration, and require little training for accurate use.
These tests play a pivotal role in the Roll Back Malaria Partnership's Global Malaria Action Plan, for which quick diagnosis of the correct malarial strain enables fast initiation of the correct treatment.
Furthermore, the rapid spread of anti-malarial drug resistance will be minimised, as treatment can be highly targeted and controlled.
